NervGen Pharma Corp. (NGEN)
1.73
-0.02
(-1.14%)
USD |
NASDAQ |
Oct 09, 16:00
1.73
0.00 (0.00%)
After-Hours: 20:00
NervGen Pharma Free Cash Flow (Quarterly) : -4.086M for June 30, 2026
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -4.086M |
| March 31, 2026 | -5.978M |
| December 31, 2025 | -4.470M |
| September 30, 2025 | -3.893M |
| June 30, 2025 | -2.750M |
| March 31, 2025 | -2.870M |
| December 31, 2024 | -2.379M |
| September 30, 2024 | -4.234M |
| June 30, 2024 | -3.022M |
| March 31, 2024 | -2.408M |
| December 31, 2023 | -2.170M |
| September 30, 2023 | -1.078M |
| June 30, 2023 | -1.514M |
| March 31, 2023 | -3.535M |
| December 31, 2022 | -3.348M |
| Date | Value |
|---|---|
| September 30, 2022 | -3.544M |
| June 30, 2022 | -2.878M |
| March 31, 2022 | -3.342M |
| December 31, 2021 | -2.263M |
| September 30, 2021 | -1.533M |
| June 30, 2021 | -1.782M |
| March 31, 2021 | -1.016M |
| December 31, 2020 | -1.571M |
| September 30, 2020 | -0.9438M |
| June 30, 2020 | -0.9077M |
| March 31, 2020 | -1.420M |
| December 31, 2019 | -1.523M |
| September 30, 2019 | -1.660M |
| June 30, 2019 | -1.001M |
| March 31, 2019 | -1.948M |
Free Cash Flow Definition
Free Cash Flow is the cash a company has left after paying for its day-to-day operations and investing in its physical assets, such as buildings, equipment and technology. The company can use that cash however it chooses: paying dividends, buying back shares, paying down debt, making acquisitions or keeping it for future growth.
Free Cash Flow (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow (Quarterly) Benchmarks
| InMed Pharmaceuticals, Inc. | -2.909M |
| Milestone Pharmaceuticals, Inc. | -22.56M |
| Clearmind Medicine, Inc. | -1.859M |
| Lexaria Bioscience Corp. | -1.661M |
| Target Group, Inc. (Canada) | -0.2294M |